Patent foramen ovale: Pathophysiology and therapeutic options in symptomatic patients

Minerva Cardioangiologica

Volumn 49, Issue 6, 2001, Pages 403-411

  Wahl, A ^a   Windecker, S ^a   Meier, B ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cerebrovascular accident; Embolism, paradoxical; Heart septal defect, atrial, physiology; Heart septal defects, atrial, diagnosis; Heart septal defects, therapy

Indexed keywords

HEART SEPTUM DEFECT; HUMAN; PARADOXICAL EMBOLISM; PATHOPHYSIOLOGY; REVIEW;

EMBOLISM, PARADOXICAL; HEART SEPTAL DEFECTS, ATRIAL; HUMAN;

EID: 0035651146     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20.
2. Arquizan C, Coste J, Touboul PJ, Mas JL. Is patent foramen ovale a family trait? A transcranial doppler sonographic study. Stroke 2001;32:1563-6.
3. Chen WJ, Kuan P, Lien WP, Lin FY. Detection of patent foramen ovale by contrast transesophageal echocardiography. Chest 1992;101:1515-20.
4. Hausmann D, Mugge A, Becht I, Daniel WG. Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol 1992;70:668-72.
5. Belkin RN, Pollack BD, Ruggiero ML, Alas LL, Tatini U. Comparison of transesophageal and transthoracic echocardiography with contrast and color flow Doppler in the detection of patent foramen ovale. Am Heart J 1994;128:520-5.
6. Sun JP, Stewart WJ, Hanna J, Thomas JD. Diagnosis of patent foramen ovale by contrast versus color Doppler by transesophageal echocardiography: relation to atrial size. Am Heart J 1996;131:239-44.
7. Di Tullio M, Sacco RL, Venketasubramanian N, Sherman D, Mohr JP, Homma S. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke 1993;24:1020-4.
8. Job FP, Ringelstein EB, Grafen Y, Flachskampf FA, Doherty C, Stockmanns A et al. Comparison of transcranial contrast Doppler sonography and transesophageal contrast echocardiography for the detection of patent foramen ovale in young stroke patients. Am J Cardiol 1994;74:381-4.
9. Klotzsch C, Janssen G, Berlit F. Transesophageal echocardiography and contrast-TCD in the detection of a patent foramen ovale: experiences with 111 patients. Neurology 1994;44:1603-6.
10. Zanette EM, Mancini G, De Castro S, Solaro M, Cartoni D, Chiarotti F. Patent foramen ovale and transcranial Doppler. Comparison of different procedures. Stroke 1996;27:2251-5.
11. Webster MW, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM et al. Patent foramen ovale in young stroke patients. Lancet 1988;2:11-2.
12. Homma S, Di Tullio MR, Sacco RL, Mihalatos D, Li Mandri G, Mohr JP. Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke 1994;25:582-6.
13. Pearson AC, Labovitz AJ, Tatineni S, Gomez CR. Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol 1991;17:66-72.
14. Thompson T, Evans W. Paradoxical embolism. Q J Med 1930;23:135-50.
15. Caes FL, Van Belleghem YV, Missault LH, Coenye KE, Van Nooten GJ. Surgical treatment of impending paradoxical embolism through patent foramen ovale. Ann Thorac Surg 1995;59:1559-61.
16. Falk V, Walther T, Krankenberg H, Mohr FW. Trapped thrombus in a patent foramen ovale. Thorac Cardiovasc Surg 1997;45:90-2.
17. Pell AC, Hughes D, Keating J, Christie J, Busuttil A, Sutherland GR. Brief report: fulminating fat embolism syndrome caused by paradoxical embolism through a patent foramen ovale. N Egl J Med 1993;329:926-9.
18. Silver MT, Lieberman EH, Thibault GE. Refractory hypoxemia in inferior myocardial infarction from right-to-left shunting through a patent foramen ovale: a case report and review of the literature Clin Cardiol 1994;17:627-30.
19. Konstantinides S, Geibel A, Kasper W, Olschewski M, Blumel L, Just H. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation 1998;97:1946-51.
20. Altman M, Robin ED. Platypnea (diffuse zone I phenomenon?). N Engl J Med 1969;281:1347-8.
21. Seward JB, Hayes DL, Smith HC, Williams DE, Rosenow EC, Reeder GS et al. Platypnea-orthodeoxia: clinical profile, diagnostic workup, management, and report of seven cases. Mayo Clin Proc 1984;59:221-31.
22. Wilmshurst PT, Byrne JC, Webb-Peploe MM. Relation between interatrial shunts and decompression sickness in divers. Lancet 1989;2:1302-6.
23. Germonpre P, Dendale P, Unger P, Balestra C. Patent foramen ovale and decompression sickness in sports divers. J Appl Physiol 1998;84:1622-6.
24. Schwerzmann M, Seiler C, Lipp E, Guzman R, Lovblad KO, Kraus M et al. Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers. Ann Intern Med 2001;134:21-4.
25. Del Sette M, Angeli S, Leandri M, Ferriero G, Bruzzone GL, Finocchi C et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 1998;8:327-30.
26. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999;52:1622-5.
27. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648-51.
28. Hart RG, Miller VT. Cerebral infarction in young adults: a practical approach. Stroke 1983;14:110-4.
29. Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989;25:382-90.
30. Steiner MM, Di Tullio MR, Rundek T, Gan R, Chen X, Liguori C et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 1998;29:944-8.
31. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-52.
32. de Belder MA, Tourikis L, Leech G, Camm AJ. Risk of patent foramen ovale for thromboembolic events in all age groups. Am J Cardiol 1992;69:1316-20.
33. Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992;117:461-5.
34. Cabanes L, Mas JL, Cohen A, Amarenco P, Cabanes PA, Oubary P et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993;24:1865-73.
35. Jones EF, Calafiore P, Donnan GA, Tonkin AM. Evidence that patent foramen ovale is not a risk factor for cerebral ischemia in the elderly. Am J Cardiol 1994;74:596-9.
36. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000;55:1172-9.
37. Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am Heart J 1995;130:1083-8.
38. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group. Neurology 1996;46:1301-5.
39. Hausmann D, Mugge A, Daniel WG. Identification of patent foramen ovale permitting paradoxic embolism. J Am Coll Cardiol 1995;26:1030-8.
40. Schuchlenz HW, Weihs W, Horner S, Quehenberger F. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med 2000;109:456-62.
41. Stone DA, Godard J, Corretti MC, Kittner SJ, Sample C. Price TR et al. Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am Heart J 1996;131:158-61.
42. Homma S, Di Tullio MR, Sacco RL, Sciacca RR, Smith C, Mohr JP. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 1997;28:2376-81.
43. Dearani JA, Ugurlu BS, Danielson GK, Daly RC, McGregor CG, Mullany CJ et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999;100:II171-5.
44. Ruchat P, Bogousslavsky J, Hurni M, Fischer AP, Jeanrenaud X, von Segesser LK. Systematic surgical closure of patent foramen ovale in selected patients with cerebrovascular events due to paradoxical embolism. Early results of a preliminary study. Eur J Cardiothorac Surg 1997;11:824-7.
45. Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, Lock JE. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992;86:1902-8.
46. Hung J, Landzberg MJ, Jenkins KJ, King ME, Lock JE, Palacios IF et al. Closure of patent foramen ovale for paradoxical emboli: intermediate-term. J Am Coll Cardiol 2000;35:1311-6.
47. Windecker S, Wahl A, Chatterjee T, Garachemani A, Eberli FR, Seiler C et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 2000;101:893-8.
48. Wahl A, Meier B, Haxel B, Nedeltchev K, Arnold M, Eicher E et al. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology 2001:in press.
49. Comess KA, De Rook FA, Beach KW, Lytle NJ, Golby AJ, Albers GW. Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: prevalence of findings and recurrent stroke risk. J Am Coll Cardiol 1994;23:1598-603.